How effective is Nuvigil for Ms (Multiple sclerosis) ?


Summary

10 Nuvigil users have rated its effectiveness for Ms.

Overall ratings: 3.5/5
Long term ratings: 3.7/5

This is a reivew of how effective Nuvigil (armodafinil) is for Ms and for what kind of people. The study is created by eHealthMe and is updated continuously.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jul, 13, 2017

10 people are studied for taking Nuvigil in Ms


Overall effectiveness (number of people)

Does Nuvigil work for your Ms (overall)?

Long term effectiveness (number of people)

Does Nuvigil work for your Ms (long term)?

Nuvigil effectiveness for Ms (number of people)

Overall:
  • not at all: 0
  • somewhat: 2
  • moderate: 2
  • high: 5
  • very high: 1
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 2
  • high: 4
  • very high: 0

Gender of people who take Nuvigil for Ms *

  • female: 90 %
  • male: 10 %

Age of people who take Nuvigil for Ms *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 10 %
  • 30-39: 20 %
  • 40-49: 20 %
  • 50-59: 30 %
  • 60+: 20 %

Who finds Nuvigil more effective for Ms?


Gender of people who take Nuvigil for Ms *

  • female: 83.33 %
  • male: 16.67 %

Age of people who take Nuvigil for Ms *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 33.33 %
  • 40-49: 16.67 %
  • 50-59: 33.33 %
  • 60+: 16.67 %

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

Nuvigil

Nuvigil has active ingredients of armodafinil. It is often used in narcolepsy. (latest outcomes from Nuvigil 13,631 users)

Ms

Ms has been reported by people with multiple sclerosis, relapsing-remitting multiple sclerosis, depression, pain, rheumatoid arthritis (latest reports from 446,677 Ms patients).

Related studies: